14 results match your criteria: "Eye Protection Foundation Bayrampasa Eye Hospital[Affiliation]"
Ocul Immunol Inflamm
September 2024
Uveitis Service, Eye Protection Foundation Bayrampasa Eye Hospital, Istanbul, Turkey.
Intermediate uveitis is a relatively common form of intraocular inflammation that can be seen at any age. The vitreous is the primary site of inflammation; and the presence of snowballs or snowbank defines its subtype, pars planitis. Since it is a clinical diagnosis, it is important to recognize the typical clinical features and associated ocular complications.
View Article and Find Full Text PDFOcul Immunol Inflamm
July 2024
The Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ocul Immunol Inflamm
May 2024
The Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ocul Immunol Inflamm
April 2024
The Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ocul Immunol Inflamm
February 2024
The Division of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Ocul Immunol Inflamm
January 2024
The Division of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Ocul Immunol Inflamm
December 2023
The Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ocul Immunol Inflamm
September 2023
The Department of Ophthalmology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Ocul Immunol Inflamm
September 2024
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Ocul Immunol Inflamm
August 2023
The Department of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Turk Arch Pediatr
July 2023
Eye Protection Foundation Bayrampaşa Eye Hospital, İstanbul, Turkey;Department of Ophthalmology, İstanbul University, İstanbul Faculty of Medicine, İstanbul, Turkey.
Saudi J Ophthalmol
December 2022
Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Clin Immunol
January 2023
Joint Rheumatology Program and First Department of Propaedeutic and Internal Medicine, National & Kapodistrian University of Athens Medical School, Athens, Greece. Electronic address:
During the last decades the efficacy of biologic agents, mainly of anti-TNFs, in controlling the activity of serious manifestations of Behcet's Disease (BD) has been established. On the other hand, the clinical heterogeneity of BD has precluded the validation of a widely-accepted composite index for disease assessment and for target disease-state definitions, such as low disease activity and remission, and the testing of their implementation in clinical practice. Therefore, in contrast to other systemic rheumatic diseases, a treat-to-target strategy has not yet been developed in BD.
View Article and Find Full Text PDFTurk J Ophthalmol
October 2022
University of Health Sciences Turkey, Beyoğlu Eye Training and Research Hospital, İstanbul, Turkey.
Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT) are relatively new clinical entities characterized by acute pigment dispersion from the iris stroma or iris pigment epithelium, respectively. While BADI presents with diffuse or geographic areas of iris stromal depigmentation without transillumination, BAIT cases typically develop diffuse iris transillumination and mydriatic atonic pupils. Prolonged pigment dispersion and ocular hypertension are more common in BAIT.
View Article and Find Full Text PDF